University of Maryland School of Medicine, Baltimore, MD, United States.
Department of Pediatrics, Division of Pulmonology/Allergy, University of Maryland School of Medicine, Baltimore, MD, United States.
Front Immunol. 2024 Jul 16;15:1425289. doi: 10.3389/fimmu.2024.1425289. eCollection 2024.
Sweet syndrome is an acute febrile neutrophilic dermatosis characterized by the infiltration of neutrophils into the skin. It may occur idiopathically or be linked to malignancies, inflammatory or autoimmune diseases. Leukocyte adhesion deficiency type I (LAD-I) is an inborn error immunity wherein leukocytes lack adhesion molecules necessary for migration to infection sites due to mutations in the CD18 gene encoding β2 integrins. We present a case of a 16-month-old female initially diagnosed and treated for Sweet syndrome based on histopathological findings with recurrent flare episodes. Subsequent workup revealed LAD-I, making this case the first documented association between Sweet syndrome and LAD-I. Moreover, we reviewed the pertinent literatures detailing the concurrence of neutrophilic dermatosis and immunodeficiency disorders. This case underscores the significance of comprehensive evaluation for Sweet syndrome patients who are refractory to conventional treatments.
Sweet 综合征是一种急性发热性中性粒细胞皮肤病,其特征是中性粒细胞浸润皮肤。它可能是特发性的,也可能与恶性肿瘤、炎症性或自身免疫性疾病有关。白细胞黏附缺陷 I 型(LAD-I)是一种先天性免疫缺陷病,由于编码β2 整合素的 CD18 基因突变,白细胞缺乏迁移到感染部位所需的黏附分子。我们报告了一例 16 个月大的女性病例,最初根据组织病理学发现诊断和治疗为 Sweet 综合征,伴有复发性发作。随后的检查发现 LAD-I,这使该病例成为首例Sweet 综合征与 LAD-I 相关的病例。此外,我们回顾了相关文献,详细描述了中性粒细胞皮肤病和免疫缺陷疾病同时发生的情况。这个病例强调了对常规治疗反应不佳的 Sweet 综合征患者进行全面评估的重要性。